Abbott Fighting FTC Infant Formula Bid-Rigging Subpoena
Infant formula manufacturer Abbott Laboratories filed an opposition brief as a backup plan in case negotiations with the Federal Trade Commission over an agency antitrust probe into its infant formula business...To view the full article, register now.
Already a subscriber? Click here to view full article